Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Invest New Drugs. 2010 Mar 23;29(5):1057–1065. doi: 10.1007/s10637-010-9413-7

Fig. 1.

Fig. 1

Demonstrates the overall survival probability of all patients screened for the TYMS*2/*2 genotype. The overall survival probability of patients with the homozygous TYMS*2 genotype was analyzed in comparison to those with either the TYMS*2/*3 or homozygous TYMS*3 genotype.